ArcticZymes Technologies ASA Navne-Aksjer NK 1
- BID
1.685
- ASK
1.795
- 3,863 Units3,625 Units
- 07/21, 10:46:50 AM
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
22.43%
Market Cap
-
P/E Ratio
108.02
Dividend Yield
0.00 %
Earnings per Share
0.02 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 1.685 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 10:31:40 AM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 1.685 | 1.675 |
| PREV. DAY'S PRICE | 1.665 | (07/20) |
| CHANGE DAY BEFORE | +0.02 | 1.20 % |
| 52 WEEK HIGH / LOW | 2.6 (10/22) | 1.27 (07/21) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 0.03 | 0.01 | 0.02 | 0.03 | 0.06 |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | 109.63 | 80.26 | 108.02 | 53.86 | 29.92 |
PRICE - BOOK RATIO | 6.91 | 2.10 | 3.11 | - | - |
PRICE - SALES RATIO | 17.95 | 6.52 | 9.34 | - | - |
PRICE - CASH FLOW RATIO | 87.41 | 410.11 | 40.77 | - | - |
Master Data
| WKN | A0HGR5 |
| ISIN | NO0010014632 |
| SYMBOL | B4V |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | ARCTICZYMES TECH ASA NK 1 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -0.89 % | -6.98 % | -6.98 % | -8.01 % | 22.43 % | -48.45 % | -80.87 % | -6.46 % |
| HIGH | 1.72 | 1.84 | 2.18 | 2.19 | 2.60 | 3.77 | 10.33 | 2.19 |
| LOW | 1.64 | 1.64 | 1.64 | 1.63 | 1.27 | 1.05 | 1.05 | 1.63 |
Dividende
pro Aktie
ARCTICZYMES TECH ASA NK 1 does not deliver dividend information
Company profile
ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. It operates through the Enzymes and Corporate segments. The Enzymes segment is composed of sales revenues and operating expenses associated with the subsidiary ArcticZymes AS, which develops and markets recombinant enzymes for use in life science research, molecular diagnostics, and bio-manufacturing. The Corporate segment provides a range of administrative services to the subsidiary. The company was founded by Jan Raa and Gunnar Rorstad in November 1990 and is headquartered in Tromso, Norway.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.